Cellusion CEO Shin Hatou will speak on “Research and development of new corneal regenerative medicine using iPS cells” at the Minaris Regenerative Medicine’s luncheon seminar at the 23rd Congress of the Japanese Society for Regenerative Medicine on March 23, 2024.